Literature DB >> 29075086

CD138 Negative Plasma Cells in Relapsed CNS Multiple Myeloma.

Neha Singh1, Jatin S Gandhi1, Narendra Agrawal2, Ajit Panaych1, Narender Tejwani1, Anurag Mehta1.   

Abstract

Entities:  

Year:  2017        PMID： 29075086      PMCID： PMC5640533          DOI： 10.1007/s12288-017-0780-5

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  6 in total

1.  CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients.

Authors:  N Hosen; Y Matsuoka; S Kishida; J Nakata; Y Mizutani; K Hasegawa; A Mugitani; H Ichihara; Y Aoyama; S Nishida; A Tsuboi; F Fujiki; N Tatsumi; H Nakajima; M Hino; T Kimura; K Yata; M Abe; Y Oka; Y Oji; A Kumanogoh; H Sugiyama
Journal:  Leukemia       Date:  2012-03-20       Impact factor: 11.528

2.  CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway.

Authors:  Dan Wu; Xinyi Guo; Jing Su; Ruoying Chen; Dmitriy Berenzon; Martin Guthold; Keith Bonin; Weiling Zhao; Xiaobo Zhou
Journal:  Biochim Biophys Acta       Date:  2014-11-21

3.  Characterisation and relevance of CD138-negative plasma cells in plasma cell myeloma.

Authors:  Samantha Reid; S Yang; R Brown; K Kabani; E Aklilu; P J Ho; N Woodland; D Joshua
Journal:  Int J Lab Hematol       Date:  2010-12       Impact factor: 2.877

Review 4.  Immunophenotyping in multiple myeloma and related plasma cell disorders.

Authors:  Shaji Kumar; Teresa Kimlinger; William Morice
Journal:  Best Pract Res Clin Haematol       Date:  2010-09       Impact factor: 3.020

5.  Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents.

Authors:  Christine I Chen; Esther Masih-Khan; Haiyan Jiang; Ahmed Rabea; Christine Cserti-Gazdewich; Victor H Jimenez-Zepeda; Chia-Min Chu; Vishal Kukreti; Suzanne Trudel; Rodger Tiedemann; Richard Tsang; Donna E Reece
Journal:  Br J Haematol       Date:  2013-06-15       Impact factor: 6.998

6.  Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide.

Authors:  Yawara Kawano; Shiho Fujiwara; Naoko Wada; Mikiko Izaki; Hiromichi Yuki; Yutaka Okuno; Kenichi Iyama; Hiroshi Yamasaki; Akira Sakai; Hiroaki Mitsuya; Hiroyuki Hata
Journal:  Int J Oncol       Date:  2012-07-04       Impact factor: 5.650
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.